Skip to main content
. Author manuscript; available in PMC: 2020 May 21.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):331–340. doi: 10.1097/QAI.0000000000000303

TABLE 2.

Prevalence of HIV Testing Among Males by Descriptive Characteristics and 4 Year Survey Periods, NHANES, 2003–2010

Variable 2003–2006 2007–2010 P*
Sample Size Percent Ever Tested 95% CI Sample Size Percent Ever Tested 95% CI
Overall 3169 37.2 34.7 to 39.8 3641 41.1 39.2 to 43.1 <0.05
Age, yr
 18–19 (ref) 500 14.9 10.5 to 19.2 294 17.3 10.6 to 24.0 NS
 20–29 742 33.3 28.2 to 38.5 817 36.4 31.9 to 40.9 NS
 30–39 669 45.7 41.5 to 49.9 847 51.2 46.5 to 56.0 NS
 40–49 708 40.4 35.3 to 45.5 834 44.9 40.0 to 49.7 NS
 50–59 550 33.4 28.7 to 38.2 849 37.0 32.3 to 41.8 NS
Race/Hispanic Origin
 Non-Hispanic white (ref) 1436 36.1 32.9 to 39.2 1565 40.3 37.7 to 42.8 <0.05
 Non-Hispanic black 794 50.3 47.1 to 53.5 721 61.7 56.6 to 66.8 <0.001
 Mexican American 701 28.9 24.0 to 33.8 779 29.7 25.3 to 34.2 NS
Education
 Less than high school diploma or GED 784 27.9 23.4 to 32.4 1011 38.7 34.1 to 43.4 <0.01
 High school diploma or GED 830 36.5 31.4 to 41.7 944 37.6 34.2 to 41.0 NS
 Above high school diploma or GED (ref) 1513 40.4 36.8 to 43.9 1666 43.6 40.9 to 46.4 NS
PIR
 Below PIR 630 38.2 33.9 to 42.5 754 39.0 35.0 to 43.1 NS
 At or above PIR (ref) 2406 37.2 34.6 to 39.8 2572 41.2 39.0 to 43.5 <0.05
Current health insurance coverage?
 Yes 2119 38.2 35.4 to 41.0 2266 41.3 39.2 to 43.3 NS
 No (ref) 1026 33.8 29.8 to 37.9 1372 40.8 37.6 to 43.9 <0.01
Regular location for health care?
 Yes 2277 38.2 34.9 to 41.5 2626 42.6 40.4 to 44.8 <0.05
 No (ref) 892 34.3 30.4 to 38.2 1015 36.3 32.2 to 40.4 NS
Received health care in the past 12 months?
 Yes 2250 39.7 36.7 to 42.8 2549 43.0 40.5 to 45.5 NS
 No (ref) 916 30.3 26.3 to 34.3 1087 36.1 32.3 to 39.9 <0.05
History of US military service?
 Yes 401 59.7 53.9 to 65.6 394 68.8 62.6 to 75.1 <0.05
 No (ref) 2768 33.1 30.5 to 35.7 3246 37.5 35.2 to 39.9 <0.05
History of injection or illicit drug use?
 Yes 771 47.4 42.5 to 52.3 882 51.7 47.1 to 56.3 NS
 No (ref) 2331 34.0 31.1 to 36.8 2678 37.8 35.7 to 39.9 <0.05
History of sexually transmitted infections?
 Yes 175 59.5 48.5 to 70.5 170 67.4 58.7 to 76.1 NS
 No (ref) 2917 35.9 33.3 to 38.5 3370 40.2 38.1 to 42.2 <0.05
Number of lifetime sexual partners
 0 371 18.2§ 13.3 to 23.1 358 24.9§ 19.4 to 30.5 NS
 1 296 17.2 12.2 to 22.3 297 23.8 18.5 to 29.1 NS
 2–4 606 27.3 21.8 to 32.9 636 27.3 24.0 to 30.6 NS
 5–9 627 33.6 29.1 to 38.1 746 40.6 35.3 to 45.8 <0.05
 10 or more 1159 53.9 50.2 to 57.5 1481 55.2 51.7 to 58.7 NS
History of same-sex sexual contact?
 Yes 149 72.5 62.5 to 82.5 172 64.7 54.8 to 74.6 NS
 No (ref) 2950 35.6 33.1 to 38.0 3377 40.3 38.4 to 42.4 <0.01
Non-heterosexual sexual identity?
 Yes 155 68.6 58.6 to 78.6 164 63.4 52.1 to 74.7 NS
 No (ref) 2939 36.0 33.7 to 38.3 3378 40.5 38.7 to 42.4 <0.01
*

Difference between 2003–2006 and 2007–2010.

P < 0.05 for t test comparing subgroup and reference group within the survey cycle.

Includes a self-reported history of chlamydia or gonorrhea in the past 12 months or a self-reported history of ever having genital herpes or genital warts.

§

P < 0.05 for linear test for trend across all subgroups for lifetime number of sexual partners within survey cycle.

Includes men who had sex with men.

Includes whether respondents thought of themselves as either non-heterosexual (homosexual, gay, bisexual, something else or not sure) or heterosexual. GED, General Educational Development; NS, not significant; ref, reference; PIR, Poverty Index Ratio.